Menu
Log in

PA logo

CVTeam Mid-Atlantic: Late Breaking Clinical Trials

maccs cvteam banner

MACCS CVTeam Education
The Late Breakers: What you must know from ACC.26

Get up to speed on the top late breaking clinical trials that were presented in New Orleans at ACC.26.  Grab your cup of coffee, log on and quickly understand what your patients are going to be asking about and how it applies to your practice. This free session will enlighten and be enjoyable. 

 

Click here and use this passcode: y!%.8071 to view a recording of the meeting. 


ACCREDITATION INFORMATION

Click here for accreditation information, including the link for CEUs.


8:00am

Welcome

8:00-8:40am

Atrial fibrillation/Pulmonary Hypertension

Moderator

Maureen Julien, CRNP, MSN

CVTeam Representative, Eastern PA

 

Outcomes in Patients with Atrial Fibirllation Randomized to Receive Left Atrial Appendage Closure of Oral Anticoagulation: Primary Results of the Champion AF Clinical Trial 

Robert Hipp PA-C

University of Pennsylvania 

HI-Peitho Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute PE

Jennifer Fox, CRNP

Lancaster General Hospital

 

Efficacy and Safety of Sotarecept in Combined Post and Pre-Capillary Pulmonary HTN Associated with Heart Failure with Preserved Ejection Fraction: Results from the Phase 2 Cadence Trial 

Jennifer Kliner, DNP, CRNP

University of Pittsburgh Medical Center Presbyterian

 

Evolocumab in Patients without Significant Atherosclerosis: Results from VESALIUS-CV

Gayley Webb, CRNP

University of Pennsylvania

8:40-9:20am

Heart Failure

Moderator

Genise Green, MSN, CRNP
CVTeam Representative, Western PA

 

Mavacamten in Symptomatic Adolescent Patients with Obstructive Hypertrophic Cardiomyopathy: Results From the Phase 3 Scout HCM-Trial 

Elizabeth M. Luttner, MS, MPAS, PA-C
Hypertrophic Cardiomyopathy and Cardiac Amyloidosis Centers
UPMC Heart and Vascular Institute

 

Long Term Survival Benefits and Disease Stabilization with Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) 

Elizabeth M. Luttner, MS, MPAS, PA-C
Hypertrophic Cardiomyopathy and Cardiac Amyloidosis Centers
UPMC Heart and Vascular Institute

 

Safety and Preliminary Efficacy of AAVrh.10hFXN (LX206) Gene Therapy in in Freidrich Ataxia Cardiomyopathy

Maria Molina, CRNP

University of Pennsylvania Medical Center

 

NOTIFY-HF: A Randomised Pilot Trial of Patient -facing Heart Logic Alerts in Heart Failure Patients 

Amber Valimont, CRNP

University of Pittsburgh Medical Center
 9:20-10:00am



Pharmacological Updates

Steven Dunn, PharmD

University of Virginia Health

Effects of Tirzepatide compared to Dulaglutide on expanded cardiorenal outcomes


10 yr follow up of Clopidogrel v Aspirin monotherapy in stable coronary artery disease after PCI with DES

 

Spironolactone in the Treatment of Heart Failure

 

Digoxin in Rheumatic Heart Disease: A Multi Center Randomized, Double Blind, Placebo controlled trial





Pennsylvania Chapter, American College of Cardiology

1554 Paoli Pike, Suite 298

West Chester, PA 19380

www.pcacc.org

Contact Us


Powered by Wild Apricot Membership Software